366 related articles for article (PubMed ID: 32848036)
1. A Critical Role of CD40 and CD70 Signaling in Conventional Type 1 Dendritic Cells in Expansion and Antitumor Efficacy of Adoptively Transferred Tumor-Specific T Cells.
Oba T; Hoki T; Yamauchi T; Keler T; Marsh HC; Cao X; Ito F
J Immunol; 2020 Oct; 205(7):1867-1877. PubMed ID: 32848036
[TBL] [Abstract][Full Text] [Related]
2. CD40 and CD80/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1
Yamauchi T; Hoki T; Oba T; Kajihara R; Attwood K; Cao X; Ito F
Cancer Immunol Immunother; 2022 Jan; 71(1):137-151. PubMed ID: 34037810
[TBL] [Abstract][Full Text] [Related]
3. T Cells Modified with CD70 as an Alternative Cellular Vaccine for Antitumor Immunity.
Lee SE; Shin AR; Sohn HJ; Cho HI; Kim TG
Cancer Res Treat; 2020 Jul; 52(3):747-763. PubMed ID: 32065848
[TBL] [Abstract][Full Text] [Related]
4. DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells.
Cueto FJ; Del Fresno C; Brandi P; Combes AJ; Hernández-García E; Sánchez-Paulete AR; Enamorado M; Bromley CP; Gomez MJ; Conde-Garrosa R; Mañes S; Zelenay S; Melero I; Iborra S; Krummel MF; Sancho D
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33980589
[TBL] [Abstract][Full Text] [Related]
5. Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cells.
Bullock TN; Yagita H
J Immunol; 2005 Jan; 174(2):710-7. PubMed ID: 15634890
[TBL] [Abstract][Full Text] [Related]
6. CD40 and CD70 co-stimulate a potent in vivo antitumor T cell response.
Nieland JD; Graus YF; Dortmans YE; Kremers BL; Kruisbeek AM
J Immunother; 1998 May; 21(3):225-36. PubMed ID: 9610915
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: a critical role for CD70 in CD8 T cell priming by CD40-licensed APCs.
Taraban VY; Rowley TF; Al-Shamkhani A
J Immunol; 2004 Dec; 173(11):6542-6. PubMed ID: 15557144
[TBL] [Abstract][Full Text] [Related]
8. CD4+ T cells elicit host immune responses to MHC class II-negative ovarian cancer through CCL5 secretion and CD40-mediated licensing of dendritic cells.
Nesbeth YC; Martinez DG; Toraya S; Scarlett UK; Cubillos-Ruiz JR; Rutkowski MR; Conejo-Garcia JR
J Immunol; 2010 May; 184(10):5654-62. PubMed ID: 20400704
[TBL] [Abstract][Full Text] [Related]
9. Manipulation of avidity to improve effectiveness of adoptively transferred CD8(+) T cells for melanoma immunotherapy in human MHC class I-transgenic mice.
Bullock TN; Mullins DW; Colella TA; Engelhard VH
J Immunol; 2001 Nov; 167(10):5824-31. PubMed ID: 11698456
[TBL] [Abstract][Full Text] [Related]
10. Differential requirement for CD70 and CD80/CD86 in dendritic cell-mediated activation of tumor-tolerized CD8 T cells.
Bak SP; Barnkob MS; Bai A; Higham EM; Wittrup KD; Chen J
J Immunol; 2012 Aug; 189(4):1708-16. PubMed ID: 22798683
[TBL] [Abstract][Full Text] [Related]
11. Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen.
Wculek SK; Amores-Iniesta J; Conde-Garrosa R; Khouili SC; Melero I; Sancho D
J Immunother Cancer; 2019 Apr; 7(1):100. PubMed ID: 30961656
[TBL] [Abstract][Full Text] [Related]
12. Comparison of OX40 ligand and CD70 in the promotion of CD4+ T cell responses.
Kurche JS; Burchill MA; Sanchez PJ; Haluszczak C; Kedl RM
J Immunol; 2010 Aug; 185(4):2106-15. PubMed ID: 20639485
[TBL] [Abstract][Full Text] [Related]
13. Agonistic antibody to CD40 boosts the antitumor activity of adoptively transferred T cells in vivo.
Liu C; Lewis CM; Lou Y; Xu C; Peng W; Yang Y; Gelbard AH; Lizée G; Zhou D; Overwijk WW; Hwu P
J Immunother; 2012 Apr; 35(3):276-82. PubMed ID: 22421945
[TBL] [Abstract][Full Text] [Related]
14. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo.
Yamada A; Salama AD; Sho M; Najafian N; Ito T; Forman JP; Kewalramani R; Sandner S; Harada H; Clarkson MR; Mandelbrot DA; Sharpe AH; Oshima H; Yagita H; Chalasani G; Lakkis FG; Auchincloss H; Sayegh MH
J Immunol; 2005 Feb; 174(3):1357-64. PubMed ID: 15661893
[TBL] [Abstract][Full Text] [Related]
15. The duration of signaling through CD40 directs biological ability of dendritic cells to induce antitumor immunity.
Watanabe S; Kagamu H; Yoshizawa H; Fujita N; Tanaka H; Tanaka J; Gejyo F
J Immunol; 2003 Dec; 171(11):5828-36. PubMed ID: 14634092
[TBL] [Abstract][Full Text] [Related]
16. Costimulatory ligand CD70 allows induction of CD8+ T-cell immunity by immature dendritic cells in a vaccination setting.
Keller AM; Xiao Y; Peperzak V; Naik SH; Borst J
Blood; 2009 May; 113(21):5167-75. PubMed ID: 19279334
[TBL] [Abstract][Full Text] [Related]
17. CD70 expression by dendritic cells plays a critical role in the immunogenicity of CD40-independent, CD4+ T cell-dependent, licensed CD8+ T cell responses.
Van Deusen KE; Rajapakse R; Bullock TN
J Leukoc Biol; 2010 Mar; 87(3):477-85. PubMed ID: 19952354
[TBL] [Abstract][Full Text] [Related]
18. Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy.
Huang J; Kerstann KW; Ahmadzadeh M; Li YF; El-Gamil M; Rosenberg SA; Robbins PF
J Immunol; 2006 Jun; 176(12):7726-35. PubMed ID: 16751420
[TBL] [Abstract][Full Text] [Related]
19. Combined TLR/CD40 stimulation mediates potent cellular immunity by regulating dendritic cell expression of CD70 in vivo.
Sanchez PJ; McWilliams JA; Haluszczak C; Yagita H; Kedl RM
J Immunol; 2007 Feb; 178(3):1564-72. PubMed ID: 17237405
[TBL] [Abstract][Full Text] [Related]
20. Multiple innate signaling pathways cooperate with CD40 to induce potent, CD70-dependent cellular immunity.
McWilliams JA; Sanchez PJ; Haluszczak C; Gapin L; Kedl RM
Vaccine; 2010 Feb; 28(6):1468-76. PubMed ID: 19995538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
